A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin

Clinical trial NCT01489696 · COMPLETED

Trial details

NCT number: NCT01489696
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cardiovascular Healthy Subjects Pharmacokinetics

Start date: 2010-08-01
Primary completion: 2011-02-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.